Results 21 to 30 of about 34,934 (250)
Generation of Virtual Patient Populations That Represent Real Type 1 Diabetes Cohorts
Mathematics, 2021 Preclinical testing and validation of therapeutic strategies developed for patients with type 1 diabetes (T1D) require a cohort of virtual patients (VPs).
Sayyar Ahmad +5 more
doaj +1 more source
Artificial Pancreas: Past, Present, Future [PDF]
Diabetes, 2011 The artificial pancreas (AP), known as closed-loop control of blood glucose in diabetes, is a system combining a glucose sensor, a control algorithm, and an insulin infusion device. AP developments can be traced back 50 years to when the possibility for external blood glucose regulation was established by studies in individuals with type 1 diabetes ...
COBELLI, CLAUDIO, Renard E, Kovatchev B.
openaire +2 more sources
Robustness of closed-loop glucose control systems [PDF]
Archives of Control Sciences, 2023 The main purpose of this work is to provide an extensive, simulation-based comparison of robustness of PID and MPC algorithms in control of blood glucose levels in patients with type 1 diabetes and thus answer the question of their safety. Cohort testing,
Artur Wyciślok, Jarosław Śmieja
doaj +1 more source
Barriers to Uptake of Insulin Technologies and Novel Solutions
Medical Devices: Evidence and Research, 2021 Meghan E Pauley, Cari Berget, Laurel H Messer, Gregory P Forlenza Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USACorrespondence: Gregory P ForlenzaBarbara Davis Center for Childhood Diabetes ...
Pauley ME +3 more
doaj
Applied System Innovation, 2020 This paper presents a comprehensive survey about the fundamental components of the artificial pancreas (AP) system including insulin administration and delivery, glucose measurement (GM), and control strategies/algorithms used for type 1 diabetes ...
Sohaib Mehmood +4 more
doaj +1 more source
The changing landscape of automated insulin delivery in the management of type 1 diabetes
Endocrine Connections, 2023 Automated insulin delivery systems, also known as closed-loop o r ‘artificial pancreas’ systems, are transforming the management of type 1 diabetes. These systems consist of an algorithm which responds to real-time glucose sensor levels by automatically ...
Rama Lakshman +2 more
doaj +1 more source
JA Clinical Reports, 2019 Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with
Kenzaburou Sugimoto +3 more
doaj +1 more source
Frontiers in Endocrinology, 2022 The aim of control strategies for artificial pancreas systems is to calculate the insulin doses required by a subject with type 1 diabetes to regulate blood glucose levels by reducing hyperglycemia and avoiding the induction of hypoglycemia.
María F. Villa-Tamayo +3 more
doaj +1 more source
A linear control of composite model for glucose insulin glucagon pump
Ain Shams Engineering Journal, 2019 Presently Type 1 diabetes is global issue and challenges for diabetes public for healthy life. Fully automatic artificial pancreas is well solution for diabetic patients to avoid the hyperglycemia/hypoglycemia as it provided the insulin/glucose when ...
Muhammad Farman +4 more
doaj +1 more source
Journal of Patient-Centered Research and Reviews, 2021 Advanced diabetes technologies have produced increasingly favorable outcomes compared to older treatments. Disparities in practice resources have led to a treatment disparity by clinical setting, where endocrinologists typically prescribe far more such ...
Alexander O’Donovan +5 more
doaj +1 more source